The use of genetically modified or disease specific model mouse, or PTH (1–84) might be more suitable to elucidate bone fracture healing in patients with hyperparathyroidism, rather than exogenous recombinant PTH1–34 (teriparatide) infusion. This evidence concerns the gene PTH and hyperparathyroidism.